SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Avanos Medical, Inc. – ‘10-K’ for 12/31/23 – ‘EX-23’

On:  Tuesday, 2/20/24, at 6:33pm ET   ·   As of:  2/21/24   ·   For:  12/31/23   ·   Accession #:  1606498-24-18   ·   File #:  1-36440

Previous ‘10-K’:  ‘10-K’ on 2/21/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   18 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/21/24  Avanos Medical, Inc.              10-K       12/31/23  114:10M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.77M 
 2: EX-19.1     Amended and Restated Policy on Insider Trading and  HTML     73K 
                Tipping                                                          
 3: EX-21       Subsidiaries of the Corporation                     HTML     35K 
 4: EX-23       Consent of Independent Registered Public            HTML     30K 
                Accounting Firm                                                  
 5: EX-24       Powers of Attorney                                  HTML     39K 
10: EX-97.1     Incentive Compensation Clawback Policy              HTML     50K 
 6: EX-31.A     Section 302 CEO Certification                       HTML     34K 
 7: EX-31.B     Section 302 CFO Certification                       HTML     34K 
 8: EX-32.A     Section 906 CEO Certification                       HTML     31K 
 9: EX-32.B     Section 906 CFO Certification                       HTML     31K 
16: R1          Cover                                               HTML     97K 
17: R2          Audit Information                                   HTML     35K 
18: R3          Consolidated Income Statements                      HTML    123K 
19: R4          Consolidated Statements of Comprehensive Income     HTML     59K 
                (Loss)                                                           
20: R5          Consolidated Balance Sheets                         HTML    148K 
21: R6          Consolidated Balance Sheets (Parenthetical)         HTML     45K 
22: R7          Consolidated Statement of Stockholders? Equity      HTML     88K 
23: R8          Consolidated Cash Flow Statements                   HTML    119K 
24: R9          Accounting Policies                                 HTML     61K 
25: R10         Discontinued Operations                             HTML     81K 
26: R11         Restructuring                                       HTML     55K 
27: R12         Goodwill                                            HTML     40K 
28: R13         Supplemental Balance Sheet Information              HTML    101K 
29: R14         Business Acquisitions                               HTML     76K 
30: R15         Leases                                              HTML     60K 
31: R16         Fair Value Information                              HTML     52K 
32: R17         Debt                                                HTML     64K 
33: R18         Income Taxes                                        HTML    110K 
34: R19         Employee Benefit Plans                              HTML     37K 
35: R20         Accumulated Other Comprehensive Income              HTML     59K 
36: R21         Stock-Based Compensation                            HTML     86K 
37: R22         Commitments and Contingencies                       HTML     40K 
38: R23         Earnings Per Share ("Eps")                          HTML     61K 
39: R24         Business and Products Information                   HTML     66K 
40: R25         Share Repurchase Program                            HTML     46K 
41: R26         Accounting Policies (Policies)                      HTML     98K 
42: R27         Discontinued Operations (Tables)                    HTML     79K 
43: R28         Restructuring (Tables)                              HTML     49K 
44: R29         Goodwill (Tables)                                   HTML     42K 
45: R30         Supplemental Balance Sheet Information (Tables)     HTML    126K 
46: R31         Business Acquisitions (Tables)                      HTML     75K 
47: R32         Leases (Tables)                                     HTML     63K 
48: R33         Fair Value Information (Tables)                     HTML     48K 
49: R34         Debt (Tables)                                       HTML     50K 
50: R35         Income Taxes (Tables)                               HTML    108K 
51: R36         Accumulated Other Comprehensive Income (Tables)     HTML     59K 
52: R37         Stock-Based Compensation (Tables)                   HTML     88K 
53: R38         Earnings Per Share ("Eps") (Tables)                 HTML     59K 
54: R39         Business and Products Information (Tables)          HTML     81K 
55: R40         Share Repurchase Program (Tables)                   HTML     41K 
56: R41         Accounting Policies - Property, Plant and           HTML     41K 
                Equipment and Depreciation (Details)                             
57: R42         Accounting Policies - Goodwill and Other            HTML     44K 
                Intangible Assets (Details)                                      
58: R43         Accounting Policies - Revenue Recognition and       HTML     60K 
                Accounts Receivable (Details)                                    
59: R44         Accounting Policies - Income Taxes (Details)        HTML     32K 
60: R45         Discontinued Operations - Narratives (Details)      HTML     59K 
61: R46         Discontinued Operations - Summary of Income         HTML     61K 
                (Details)                                                        
62: R47         Discontinued Operations - Summary of Balance Sheet  HTML     65K 
                (Details)                                                        
63: R48         Discontinued Operations- Summary of Cashflow        HTML     41K 
                (Details)                                                        
64: R49         Restructuring - Restructuring Expense (Details)     HTML     41K 
65: R50         Restructuring - Narrative (Details)                 HTML     61K 
66: R51         Restructuring - Accrual and Payment Activity        HTML     39K 
                (Details)                                                        
67: R52         Goodwill - Narrative (Details)                      HTML     32K 
68: R53         Goodwill - Summary of Goodwill (Details)            HTML     47K 
69: R54         Supplemental Balance Sheet Information - Accounts   HTML     49K 
                receivable (Details)                                             
70: R55         Supplemental Balance Sheet Information -            HTML     40K 
                Inventories (Details)                                            
71: R56         Supplemental Balance Sheet Information - Narrative  HTML     39K 
                (Details)                                                        
72: R57         Supplemental Balance Sheet Information - Property,  HTML     57K 
                Plant and Equipment (Details)                                    
73: R58         Supplemental Balance Sheet Information -            HTML     46K 
                Intangible Assets (Details)                                      
74: R59         Supplemental Balance Sheet Information - Estimated  HTML     46K 
                Amortization Expense (Details)                                   
75: R60         Supplemental Balance Sheet Information - Accrued    HTML     40K 
                Expenses (Details)                                               
76: R61         Supplemental Balance Sheet Information - Other      HTML     36K 
                Long-Term Liabilities (Details)                                  
77: R62         Business Acquisitions - Narrative (Details)         HTML     57K 
78: R63         Business Acquisitions - Purchase Price Allocation   HTML     71K 
                (Details)                                                        
79: R64         Business Acquisitions - Finite-Lived Intangible     HTML     50K 
                Assets (Details)                                                 
80: R65         Business Acquisitions - Pro-Forma Information       HTML     55K 
                (Details)                                                        
81: R66         Leases - ROU Assets and Lease Liabilities           HTML     42K 
                (Details)                                                        
82: R67         Leases - Cost and Cash Flows From Lease Agreements  HTML     43K 
                (Details)                                                        
83: R68         Leases - Future Minimum Obligations Under           HTML     46K 
                Operating Leases (Details)                                       
84: R69         Fair Value Information (Details)                    HTML     52K 
85: R70         Debt - Debt Balances (Details)                      HTML     55K 
86: R71         Debt - Narratives (Details)                         HTML    103K 
87: R72         Debt - Maturities of Long-Term Debt (Details)       HTML     44K 
88: R73         Income Taxes - Provision for Income Taxes           HTML     70K 
                (Details)                                                        
89: R74         Income Taxes - Narrative (Details)                  HTML     51K 
90: R75         Income Taxes - Reconciliation of Federal Statutory  HTML     61K 
                Rate and Effective Rate (Details)                                
91: R76         Income Taxes - Components of Deferred Tax Assets    HTML     72K 
                and Liabilities (Details)                                        
92: R77         Employee Benefit Plans - Defined Contribution       HTML     32K 
                Plans (Details)                                                  
93: R78         Employee Benefit Plans - Defined Benefit Plans      HTML     39K 
                (Details)                                                        
94: R79         Accumulated Other Comprehensive Income - Changes    HTML     49K 
                in Components of Accumulated Other Comprehensive                 
                Income, net of tax (Details)                                     
95: R80         Accumulated Other Comprehensive Income - Net        HTML     45K 
                Changes in Components of AOCI, Including Tax                     
                Effect (Details)                                                 
96: R81         Stock-Based Compensation - Narrative (Details)      HTML     84K 
97: R82         Stock-Based Compensation - Stock-Based              HTML     49K 
                Compensation Expense (Details)                                   
98: R83         Stock-Based Compensation - Stock Option Activity    HTML     64K 
                (Details)                                                        
99: R84         Stock-Based Compensation - Options Outstanding, by  HTML     56K 
                Exercise Price Range (Details)                                   
100: R85         Stock-Based Compensation - Restricted Stock Units   HTML     54K  
                Activity (Details)                                               
101: R86         Stock-Based Compensation - Performance Shares       HTML     49K  
                Activity (Details)                                               
102: R87         Commitments and Contingencies - Narrative           HTML     36K  
                (Details)                                                        
103: R88         Earnings Per Share ("Eps") (Details)                HTML    100K  
104: R89         Business and Products Information - Narrative       HTML     42K  
                (Details)                                                        
105: R90         Business and Products Information - Net Sales by    HTML     46K  
                Product Category (Details)                                       
106: R91         Business and Products Information - Accrued         HTML     38K  
                Liabilities (Details)                                            
107: R92         Business and Products Information - Property,       HTML     37K  
                plant and equipment (Details)                                    
108: R93         Share Repurchase Program - Narrative (Details)      HTML     37K  
109: R94         Share Repurchase Program - Purchase Activity        HTML     41K  
                (Details)                                                        
111: XML         IDEA XML File -- Filing Summary                      XML    200K  
114: XML         XBRL Instance -- avns-20231231_htm                   XML   2.09M  
110: EXCEL       IDEA Workbook of Financial Report Info              XLSX    192K  
12: EX-101.CAL  XBRL Calculations -- avns-20231231_cal               XML    326K 
13: EX-101.DEF  XBRL Definitions -- avns-20231231_def                XML    755K 
14: EX-101.LAB  XBRL Labels -- avns-20231231_lab                     XML   2.06M 
15: EX-101.PRE  XBRL Presentations -- avns-20231231_pre              XML   1.31M 
11: EX-101.SCH  XBRL Schema -- avns-20231231                         XSD    205K 
112: JSON        XBRL Instance as JSON Data -- MetaLinks              586±   884K  
113: ZIP         XBRL Zipped Folder -- 0001606498-24-000018-xbrl      Zip    641K  


‘EX-23’   —   Consent of Independent Registered Public Accounting Firm


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  

Exhibit No. 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM






We consent to the incorporation by reference in Registration Statement Nos. 333-199748, 333-233071, 333-258016 and 333-273234 on Form S-8 of our reports dated February 21, 2024, relating to the consolidated financial statements of Avanos Medical, Inc. and subsidiaries (the “Company”), and the effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of Avanos Medical, Inc. for the year ended December 31, 2023.



/s/ DELOITTE & TOUCHE LLP  
Deloitte & Touche LLP
Atlanta, Georgia
February 21, 2024


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed as of:2/21/24
Filed on:2/20/248-K
For Period end:12/31/23
 List all Filings 


18 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/02/23  Avanos Medical, Inc.              8-K:2,9    10/02/23   11:244K
 8/09/23  Avanos Medical, Inc.              10-Q        6/30/23   77:7.1M
 7/13/23  Avanos Medical, Inc.              S-8         7/13/23    6:270K
 5/03/23  Avanos Medical, Inc.              10-Q        3/31/23   70:5.3M
 2/21/23  Avanos Medical, Inc.              10-K       12/31/22  116:11M
 8/09/22  Avanos Medical, Inc.              10-Q        6/30/22   73:9.6M
 1/21/22  Avanos Medical, Inc.              8-K:2,9     1/20/22   13:3.6M
 8/03/21  Avanos Medical, Inc.              10-Q        6/30/21   65:5.6M
 7/09/21  Avanos Medical, Inc.              8-K:1,9     7/06/21   11:483K
 2/19/21  Avanos Medical, Inc.              10-K       12/31/20  109:11M
11/03/20  Avanos Medical, Inc.              10-Q        9/30/20   69:5.5M
 5/06/20  Avanos Medical, Inc.              8-K:2,5,9   4/30/20   15:920K
12/30/19  Avanos Medical, Inc.              8-K:5,9    12/30/19   14:277K
 8/07/19  Avanos Medical, Inc.              S-8         8/07/19    5:231K
 5/02/18  Avanos Medical, Inc.              10-Q        3/31/18   72:8.3M
10/31/17  Avanos Medical, Inc.              8-K:5,9    10/31/17    3:356K
 6/23/17  Avanos Medical, Inc.              8-K:5,7,9   6/23/17    3:72K
11/04/14  Avanos Medical, Inc.              8-K:1,2,5,810/31/14   19:5.1M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001606498-24-000018   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 11:32:54.1pm ET